Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • 2'3'-cGAMP (sodium salt): Reference STING Agonist for Inn...

    2025-12-11

    2'3'-cGAMP (sodium salt): Reference STING Agonist for Innate Immunity

    Executive Summary: 2'3'-cGAMP (sodium salt) is an endogenous cyclic dinucleotide generated by cGAS upon sensing cytosolic double-stranded DNA [APExBIO]. It binds to the STING protein with nanomolar affinity (Kd = 3.79 nM), surpassing other cyclic dinucleotides [Chini et al., 2025]. Upon binding, it robustly induces type I interferon (IFN-β) via TBK1/IRF3 activation. This compound is widely used in research on innate immune signaling, cancer immunotherapy, and antiviral responses. 2'3'-cGAMP (sodium salt) is a chemically defined, highly soluble molecule, stable at -20°C, and available from APExBIO as SKU B8362.

    Biological Rationale

    2'3'-cGAMP (sodium salt) is an endogenous second messenger produced in mammalian cells by cyclic GMP-AMP synthase (cGAS). cGAS becomes activated upon detection of cytosolic double-stranded DNA, which can result from viral infection, cellular damage, or mitochondrial DNA leakage [Chini et al., 2025]. The cGAS-STING pathway is a central axis in innate immune surveillance. Activation of this pathway results in transcriptional upregulation of type I interferons and other antiviral genes. Dysregulation of cGAS-STING signaling is implicated in inflammatory diseases, cancer, and age-related pathologies. Chronic NAD depletion, as shown in fibroblast models, triggers mitochondrial DNA leakage and cGAS-STING-dependent interferon responses [Chini et al., 2025]. Thus, 2'3'-cGAMP (sodium salt) is a critical reagent for modeling and dissecting these processes in vitro and in vivo.

    Mechanism of Action of 2'3'-cGAMP (sodium salt)

    2'3'-cGAMP (sodium salt) is synthesized in cells by cGAS using ATP and GTP as substrates. The product, adenylyl-(3'→5')-2'-guanylic acid (cyclic), forms a unique 2'-5', 3'-5' phosphodiester linkage [APExBIO]. Once formed, 2'3'-cGAMP diffuses to the endoplasmic reticulum where it binds directly to STING (stimulator of interferon genes). This binding induces a conformational change in STING, promoting its trafficking and recruitment of TBK1 kinase. TBK1 phosphorylates IRF3, which then translocates to the nucleus and initiates transcription of IFN-β and other interferon-stimulated genes. This cascade is essential for effective antiviral and antitumor immunity [Chini et al., 2025]. 2'3'-cGAMP displays much higher affinity for mammalian STING compared to bacterial cyclic dinucleotides, making it a precise agonist for mammalian systems [Site Article].

    Evidence & Benchmarks

    • 2'3'-cGAMP directly activates the STING pathway, resulting in robust type I interferon induction in multiple mammalian cell types (NIH3T3, IMR90, HS5) (Chini et al., 2025).
    • The affinity of 2'3'-cGAMP for human STING is Kd = 3.79 nM, higher than canonical bacterial CDNs (APExBIO).
    • Chronic NAD depletion triggers VDAC1-mediated mitochondrial DNA leakage, activating cGAS and generating 2'3'-cGAMP, which is required for interferon signaling in this context (Chini et al., 2025).
    • Pharmacological inhibition of STING or VDAC1 oligomerization abrogates the interferon response induced by endogenous 2'3'-cGAMP (Chini et al., 2025).
    • 2'3'-cGAMP (sodium salt) is water-soluble at ≥7.56 mg/mL but insoluble in ethanol and DMSO, enabling high-concentration aqueous applications (APExBIO).
    • For in vitro use, the compound remains stable when stored at -20°C and protected from repeated freeze-thaw cycles (APExBIO).

    This article extends the benchmarking focus of "2'3'-cGAMP (sodium salt): Benchmarking the Gold Standard ..." by integrating recent mechanistic findings and translational insights, addressing both molecular benchmarks and workflow integration. For additional systems-level context, see "2'3'-cGAMP (sodium salt): Systems Immunology and Translat...", which discusses how this agonist enables multi-scale modeling; this article clarifies specific use-cases and parameterization. For the latest on translational design, "Beyond Canonical Pathways: Harnessing 2'3'-cGAMP (Sodium ...)" explores clinical applications, while this article emphasizes validated laboratory workflows and pitfalls.

    Applications, Limits & Misconceptions

    2'3'-cGAMP (sodium salt) is used in:

    • Dissecting cGAS-STING pathway activation in immunology and inflammation research.
    • Modeling interferon responses in cancer biology and screening of STING-targeted therapeutics.
    • Investigating mechanisms of antiviral innate immunity and mitochondrial DNA-driven inflammation.
    • In vivo studies of tumor immunogenicity and vaccine adjuvant effects.

    Common Pitfalls or Misconceptions

    • 2'3'-cGAMP (sodium salt) does not activate non-mammalian STING homologs efficiently; species specificity must be considered [Chini et al., 2025].
    • It is ineffective if the STING pathway is genetically disrupted downstream (e.g., TBK1, IRF3 knockout models).
    • The compound is unstable in repeated freeze-thaw cycles; improper storage reduces activity [APExBIO].
    • It is not suitable for applications requiring solubility in organic solvents like DMSO or ethanol.
    • 2'3'-cGAMP is not a direct antiviral agent; its effects are mediated by host immune signaling.

    Workflow Integration & Parameters

    • Prepare 2'3'-cGAMP (sodium salt) in sterile water (≥7.56 mg/mL) immediately before use for maximal potency [APExBIO].
    • Recommended storage: -20°C, minimize freeze-thaw cycles.
    • Typical in vitro concentrations: 0.1–10 µM, titrated for cell type and endpoint.
    • In vivo dosage and delivery route should be optimized per animal model and experimental endpoint.
    • Monitor downstream markers (IFNB1, ISGs) by qPCR or ELISA to confirm functional activation.
    • Use appropriate negative controls (e.g., STING inhibitors or knockouts) to validate specificity.

    Conclusion & Outlook

    2'3'-cGAMP (sodium salt) is a validated, high-affinity agonist for mammalian STING, enabling precise dissection of cGAS-STING pathway biology. Its physicochemical stability, solubility in water, and robust biological activity support its use in preclinical immunology, cancer, and antiviral research. As new insights emerge into cGAS-STING signaling in disease, 2'3'-cGAMP (sodium salt) remains essential for mechanistic studies and therapeutic screening. For detailed specifications and ordering, see the APExBIO product page (B8362).